Inventor · disambiguated record
Robert B. Dubridge
Also filed as: DUBRIDGE ROBERT · DUBRIDGE ROBERT B · DUBRIDGE ROBERT BRYAN
48 granted patents·20 pending applications·2,111 citations·filing 1993–2023
98Inventor score
Files withHARPOON THERAPEUTICS INC16TAKEDA PHARMACEUTICALS CO10FULL SPECTRUM GENETICS INC6LYNX THERAPEUTICS INC6ABBVIE BIOTHERAPEUTICS INC4
Top patents by PatentIndex Score
68 records- 0198US6013445AMassively parallel signature sequencing by ligation of encoded adaptorsLYNX THERAPEUTICS INC·Filed 1997·Granted Jan 11, 2000·617 cites·29 claims
- 0296US10543271B2Mesothelin binding proteinsHARPOON THERAPEUTICS INC·Filed 2018·Granted Jan 28, 2020·13 cites·18 claims
- 0396US10100106B2Single domain serum albumin binding proteinHARPOON THERAPEUTICS INC·Filed 2017·Granted Oct 16, 2018·27 cites·26 claims
- 0496US9920115B2Single domain serum albumin binding proteinHARPOON THERAPEUTICS INC·Filed 2017·Granted Mar 20, 2018·31 cites·12 claims
- 0596US5714330ADNA sequencing by stepwise ligation and cleavageLYNX THERAPEUTICS INC·Filed 1996·Granted Feb 3, 1998·446 cites·28 claims
- 0695US11085021B2Compositions and methods for TCR reprogramming using fusion proteinsTCR2 THERAPEUTICS INC·Filed 2020·Granted Aug 10, 2021·3 cites·27 claims
- 0795US10849973B2Prostate specific membrane antigen binding proteinHARPOON THERAPEUTICS INC·Filed 2017·Granted Dec 1, 2020·10 cites·8 claims
- 0895US10844134B2PSMA targeting trispecific proteins and methods of useHARPOON THERAPEUTICS INC·Filed 2017·Granted Nov 24, 2020·12 cites·11 claims
- 0995US10730954B2MSLN targeting trispecific proteins and methods of useHARPOON THERAPEUTICS INC·Filed 2018·Granted Aug 4, 2020·14 cites·2 claims
- 1095US10066016B2Single chain variable fragment CD3 binding proteinsHARPOON THERAPEUTICS INC·Filed 2017·Granted Sep 4, 2018·34 cites·13 claims
- 1194US11744892B2Constrained conditionally activated binding proteinsTAKEDA PHARMACEUTICALS CO·Filed 2022·Granted Sep 5, 2023·2 cites·1 claims
- 1294US11744893B2Constrained conditionally activated binding proteinsTAKEDA PHARMACEUTICALS CO·Filed 2022·Granted Sep 5, 2023·2 cites·1 claims
- 1393US11406710B2Constrained conditionally activated binding proteinsTAKEDA PHARMACEUTICALS CO·Filed 2018·Granted Aug 9, 2022·8 cites·13 claims
- 1492US12128102B2Constrained conditionally activated binding proteinsTAKEDA PHARMACEUTICALS CO·Filed 2023·Granted Oct 29, 2024·1 cites·15 claims
- 1592US10544221B2Single chain variable fragment CD3 binding proteinsHARPOON THERAPEUTICS INC·Filed 2017·Granted Jan 28, 2020·14 cites·17 claims
- 1692US5888737AAdaptor-based sequence analysisLYNX THERAPEUTICS INC·Filed 1997·Granted Mar 30, 1999·214 cites·36 claims
- 1791US9079953B2Anti-VEGF antibodies and their usesHARDING FIONA A·Filed 2010·Granted Jul 14, 2015·23 cites·11 claims
- 1891US6514752B1Homologous recombination for universal donor cells and chimeric mammalian hostsCELL GENESYS INC·Filed 1995·Granted Feb 4, 2003·60 cites·14 claims
- 1991US6265163B1Solid phase selection of differentially expressed genesLYNX THERAPEUTICS INC·Filed 1998·Granted Jul 24, 2001·104 cites·16 claims
- 2091US5574205AHomologous recombination for universal donor cells and chimeric mammalian hostsCELL GENESYS·Filed 1993·Granted Nov 12, 1996·114 cites·8 claims
- 2190US8937159B2Anti-HER2 antibodies and their usesHARDING FIONA A·Filed 2010·Granted Jan 20, 2015·12 cites·16 claims
- 2290US7947495B2Immunoglobulin display vectorsABBOTT BIOTHERAPEUTICS CORP·Filed 2008·Granted May 24, 2011·18 cites·16 claims
- 2390US6139835AHomologous recombination for allogeneic donor cellsCELL GENESYS INC·Filed 1995·Granted Oct 31, 2000·54 cites·62 claims
- 2489US9963509B2Anti-B7H3 binding compounds and uses thereofFULL SPECTRUM GENETICS INC·Filed 2015·Granted May 8, 2018·6 cites·14 claims
- 2589US8642557B2CTLA4 proteins and their usesAKAMATSU YOSHIKO·Filed 2011·Granted Feb 4, 2014·15 cites·43 claims
- 2689USRE43097EMassively parallel signature sequencing by ligation of encoded adaptorsALBRECHT GLENN·Filed 2010·Granted Jan 10, 2012·14 cites·29 claims
- 2788US9587007B2CTLA4 proteins and their usesABBVIE BIOTHERAPEUTICS INC·Filed 2014·Granted Mar 7, 2017·8 cites·19 claims
- 2888US8633139B2Methods of screening complex protein libraries to identify altered propertiesDUBRIDGE ROBERT·Filed 2008·Granted Jan 21, 2014·12 cites·20 claims
- 2987US11685780B2Single domain antigen binding domains that bind human Trop2TAKEDA PHARMACEUTICALS CO·Filed 2020·Granted Jun 27, 2023·2 cites·20 claims
- 3087US9315573B2Anti-TNF-alpha antibodies and their usesABBVIE BIOTHERAPEUTICS INC·Filed 2014·Granted Apr 19, 2016·9 cites·36 claims
- 3187US7807163B2Antibodies against GPR64 and uses thereofFACET BIOTECH CORP·Filed 2008·Granted Oct 5, 2010·7 cites·37 claims
- 3286US8883971B2CTLA4 proteins and their usesABBVIE BIOTHERAPEUTICS INC·Filed 2013·Granted Nov 11, 2014·7 cites·19 claims
- 3385US6175002B1Adaptor-based sequence analysisLYNX THERAPEUTICS INC·Filed 1999·Granted Jan 16, 2001·94 cites·8 claims
- 3484US10865245B2Anti-B7H3 binding compounds and uses thereofFULL SPECTRUM GENETICS INC·Filed 2018·Granted Dec 15, 2020·3 cites·21 claims
- 3583US12478673B2Constrained conditionally activated binding proteinsTAKEDA PHARMACEUTICALS CO·Filed 2023·Granted Nov 25, 2025·0 cites·21 claims
- 3682US8658175B2Anti-EGFR antibodies and their usesDUBRIDGE ROBERT B·Filed 2010·Granted Feb 25, 2014·13 cites·41 claims
- 3782US7276372B2Antibodies against GPR64 and uses thereofPDL BIOPHARMA INC·Filed 2003·Granted Oct 2, 2007·12 cites·20 claims
- 3881US11623958B2Single chain variable fragment CD3 binding proteinsHARPOON THERAPEUTICS INC·Filed 2020·Granted Apr 11, 2023·1 cites·24 claims
- 3980US11453716B2Single domain serum albumin binding proteinHARPOON THERAPEUTICS INC·Filed 2018·Granted Sep 27, 2022·1 cites·20 claims
- 4080US5670148ACombined cellular and immunosuppressive therapiesCELL GENESYS INC·Filed 1994·Granted Sep 23, 1997·42 cites·6 claims
- 4176US2024100157A1Mesothelin binding proteinsHARPOON THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 4271US2024199739A1Constrained conditionally activated binding proteinsTAKEDA PHARMACEUTICALS CO·Filed 2023·Application pending·0 cites
- 4371US2024084009A1Single chain variable fragment cd3 binding proteinsHARPOON THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 4469US11607453B2Mesothelin binding proteinsHARPOON THERAPEUTICS INC·Filed 2020·Granted Mar 21, 2023·0 cites·19 claims
- 4569US8722860B2Anti-TNF-α antibodies and their usesHARDING FIONA A·Filed 2010·Granted May 13, 2014·1 cites·36 claims
- 4669US8283170B2Immunoglobulin display vectorsDUBRIDGE ROBERT·Filed 2011·Granted Oct 9, 2012·1 cites·15 claims
- 4769US6511802B1Solid phase selection of differentially expressed genesLYNX THERAPEUTICS INC·Filed 1999·Granted Jan 28, 2003·30 cites·43 claims
- 4864US7547544B2Antibodies against GPR64 and uses thereofFACET BIOTECH CORP·Filed 2007·Granted Jun 16, 2009·0 cites·18 claims
- 4963US11332735B2Method of improving characteristics of proteinsFULL SPECTRUM GENETICS INC·Filed 2020·Granted May 17, 2022·0 cites·7 claims
- 5061US2021100902A1Prostate specific membrane antigen binding proteinHARPOON THERAPEUTICS INC·Filed 2020·Application pending·0 cites
Showing the top 50 of 68 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →